Skip to main content
. 2016 Feb 18;2016:3948795. doi: 10.1155/2016/3948795

Table 2.

Clinical primary outcomes.

Primary outcome measures Study group (n = 40) Control group (n = 42) Relative risk (95% CI) P value
28-day mortality (all causes) 20/40 (50%) 33/42 (78.58%) 0.636 (0.449–0.901) 0.007
28-day mortality (hospitalization) 7/40 (17.5%) 23/42 (54.76%) 0.320 (0.154–0.661) <0.001